Charities and the lure of capitalism: Philanthropies dedicated to finding cures for rare diseases explore new models for funding and cooperation to accelerate research and drug development

Many charities employ funding schemes from venture capital to accelerate research and drug development for rare diseases. Though it has yielded new treatments, venture philanthropy prompts raises criticism about the role of charities in marketing and pricing their drugs. [Image: see text]